Menu
Our mission is to transform patient care by expanding access to data-driven medicine globally.
Join us as we democratize data-driven medicine, together.
SOPHiA GENETICS was founded in 2011 by biologists who saw an opportunity to address the growing need for answers to diseases of the DNA. They believed technology could make a positive and lasting impact on the world, using data for good.
Their vision was to build a future in which each patient has equal access to world-class care, and today, we are well underway to realizing that impact. We’ve built a revolutionary technology platform that distills complex data into actionable insights to reshape the way that cancer and rare inherited disorders are diagnosed and treated.
We’re pioneering the field of data-driven medicine, where our platform’s AI-driven insights, at the heart of one of the strongest connected networks in the world, benefit patients both today and tomorrow.
Our science is driven by unrelenting passion to transform patient care through technology and collaboration.
We are innovators across verticals, cultures and borders, who are passionate and engaged. We’re not afraid to roll our sleeves up to put in the hard work, but we have fun while doing it. We work hard, with precision, and progress as a team, not as individuals.
We wouldn’t be able to achieve all that we have, and all that we will, without our people, who are propelled forward by our company mantra: We Care.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
